Jane Street’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $149M | Buy |
1,065,800
+225,200
| +27% | +$31.5M | 0.02% | 488 |
|
|
2025
Q4 | $103M | Buy |
840,600
+288,800
| +52% | +$35.1M | 0.02% | 573 |
|
|
2025
Q3 | $61.2M | Sell |
551,800
-117,700
| -18% | -$13.4M | 0.01% | 847 |
|
|
2025
Q2 | $74.2M | Buy |
669,500
+209,900
| +46% | +$22.3M | 0.01% | 578 |
|
|
2025
Q1 | $51.5M | Buy |
459,600
+78,900
| +21% | +$8.14M | 0.01% | 652 |
|
|
2024
Q4 | $35.2M | Sell |
380,700
-62,900
| -14% | -$5.66M | 0.01% | 883 |
|
|
2024
Q3 | $37.2M | Sell |
443,600
-1,155,400
| -72% | -$88.2M | 0.01% | 839 |
|
|
2024
Q2 | $110M | Buy |
1,599,000
+1,330,400
| +495% | +$88.8M | 0.03% | 372 |
|
|
2024
Q1 | $19.7M | Buy |
268,600
+41,300
| +18% | +$3.18M | ﹤0.01% | 1197 |
|
|
2023
Q4 | $18.4M | Sell |
227,300
-92,400
| -29% | -$7.19M | ﹤0.01% | 1351 |
|
|
2023
Q3 | $24M | Sell |
319,700
-581,100
| -65% | -$44.7M | 0.01% | 963 |
|
|
2023
Q2 | $69.4M | Sell |
900,800
-102,500
| -10% | -$8.17M | 0.02% | 461 |
|
|
2023
Q1 | $83.2M | Buy |
1,003,300
+578,200
| +136% | +$47.9M | 0.03% | 351 |
|
|
2022
Q4 | $36.5M | Sell |
425,100
-2,035,700
| -83% | -$161M | 0.02% | 664 |
|
|
2022
Q3 | $152M | Buy |
2,460,800
+140,200
| +6% | +$8.84M | 0.07% | 176 |
|
|
2022
Q2 | $143M | Buy |
2,320,600
+318,500
| +16% | +$19.7M | 0.06% | 211 |
|
|
2022
Q1 | $119M | Buy |
2,002,100
+2,400
| +0.1% | +$153K | 0.04% | 324 |
|
|
2021
Q4 | $145M | Buy |
1,999,700
+1,112,800
| +125% | +$76.6M | 0.05% | 254 |
|
|
2021
Q3 | $62M | Buy |
886,900
+160,100
| +22% | +$11.2M | 0.02% | 515 |
|
|
2021
Q2 | $50M | Sell |
726,800
-700,500
| -49% | -$46.8M | 0.02% | 551 |
|
|
2021
Q1 | $92.2M | Sell |
1,427,300
-447,400
| -24% | -$28.8M | 0.05% | 297 |
|
|
2020
Q4 | $109M | Sell |
1,874,700
-1,145,300
| -38% | -$69.1M | 0.05% | 221 |
|
|
2020
Q3 | $191M | Sell |
3,020,000
-1,596,100
| -35% | -$111M | 0.11% | 114 |
|
|
2020
Q2 | $355M | Buy |
4,616,100
+748,200
| +19% | +$57.3M | 0.27% | 52 |
|
|
2020
Q1 | $289M | Buy |
3,867,900
+3,514,300
| +994% | +$243M | 0.28% | 53 |
|
|
2019
Q4 | $23M | Buy |
353,600
+251,800
| +247% | +$16.4M | 0.03% | 339 |
|
|
2019
Q3 | $6.45M | Sell |
101,800
-116,300
| -53% | -$7.6M | 0.01% | 822 |
|
|
2019
Q2 | $14.7M | Buy |
218,100
+57,500
| +36% | +$3.78M | 0.03% | 477 |
|
|
2019
Q1 | $10.4M | Sell |
160,600
-192,600
| -55% | -$12.8M | 0.02% | 661 |
|
|
2018
Q4 | $22.1M | Buy |
353,200
+154,800
| +78% | +$10.8M | 0.05% | 287 |
|
|
2018
Q3 | $15.3M | Sell |
198,400
-51,300
| -21% | -$3.87M | 0.03% | 419 |
|
|
2018
Q2 | $17.7M | Buy |
249,700
+2,200
| +0.9% | +$155K | 0.04% | 350 |
|
|
2018
Q1 | $18.7M | Buy |
247,500
+97,000
| +64% | +$7.71M | 0.05% | 314 |
|
|
2017
Q4 | $10.8M | Sell |
150,500
-40,700
| -21% | -$3.09M | 0.03% | 485 |
|
|
2017
Q3 | $15.5M | Sell |
191,200
-92,100
| -33% | -$7.04M | 0.05% | 351 |
|
|
2017
Q2 | $20.1M | Buy |
283,300
+245,200
| +644% | +$16.3M | 0.07% | 246 |
|
|
2017
Q1 | $2.59M | Sell |
38,100
-9,400
| -20% | -$661K | 0.01% | 1142 |
|
|
2016
Q4 | $3.4M | Sell |
47,500
-257,600
| -84% | -$19.1M | 0.01% | 918 |
|
|
2016
Q3 | $24.1M | Buy |
305,100
+56,000
| +22% | +$4.55M | 0.12% | 159 |
|
|
2016
Q2 | $20.8M | Buy |
249,100
+102,700
| +70% | +$9.11M | 0.1% | 180 |
|
|
2016
Q1 | $13.4M | Sell |
146,400
-7,000
| -5% | -$631K | 0.08% | 229 |
|
|
2015
Q4 | $15.5M | Sell |
153,400
-69,700
| -31% | -$7.25M | 0.1% | 187 |
|
|
2015
Q3 | $21.9M | Buy |
223,100
+93,900
| +73% | +$10.4M | 0.14% | 122 |
|
|
2015
Q2 | $15.1M | Buy |
129,200
+2,300
| +2% | +$251K | 0.1% | 150 |
|
|
2015
Q1 | $12.5M | Sell |
126,900
-5,000
| -4% | -$508K | 0.1% | 170 |
|
|
2014
Q4 | $12.4M | Buy |
131,900
+103,500
| +364% | +$10.7M | 0.09% | 160 |
|
|
2014
Q3 | $3.02M | Buy |
+28,400
| New | +$2.78M | 0.03% | 429 |
|
|
2014
Q2 | – | Sell |
-150,000
| Closed | -$10.6M | – | 2768 |
|
|
2014
Q1 | $10.6M | Buy |
+150,000
| New | +$11.8M | 0.12% | 122 |
|
Other funds holding GILD
VCM
VPM
Jane Street's GILD Position: Q1 2026 in Review
Jane Street increased its Gilead Sciences (GILD) stake by 1,000% in Q1 2026, buying an estimated $84.9M and bringing the position to 666,637 shares worth $92.9M. The position accounts for 0.01% of the portfolio, ranked #677.
Jane Street first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $98.2M in Q3 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Jane Street held 666,637 shares of Gilead Sciences worth $92.9M as of Q1 2026.
- Jane Street bought 606,009 Gilead Sciences shares in Q1 2026, an estimated $84.9M.
- Gilead Sciences made up 0.01% of Jane Street's portfolio in Q1 2026, its #677 holding.
- Jane Street first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Jane Street's Gilead Sciences position peaked at $98.2M in Q3 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.